A detailed history of Creative One Wealth, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Creative One Wealth, LLC holds 208 shares of REGN stock, worth $217,289. This represents 0.01% of its overall portfolio holdings.

Number of Shares
208
Holding current value
$217,289
% of portfolio
0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$902.69 - $993.35 $187,759 - $206,616
208 New
208 $200,000
Q1 2023

May 15, 2023

SELL
$680.49 - $826.97 $4,763 - $5,788
-7 Reduced 2.13%
321 $264,000
Q4 2022

Feb 14, 2023

BUY
$705.89 - $766.39 $26,117 - $28,356
37 Added 12.71%
328 $237,000
Q3 2022

Nov 14, 2022

BUY
$573.97 - $724.32 $167,025 - $210,777
291 New
291 $200,000
Q2 2022

Aug 12, 2022

SELL
$548.35 - $738.84 $195,760 - $263,765
-357 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$595.12 - $698.43 $212,457 - $249,339
357 New
357 $249,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $112B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Creative One Wealth, LLC Portfolio

Follow Creative One Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative One Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Creative One Wealth, LLC with notifications on news.